Pancreatic Cancer Research

ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteNo recent work listed

Moumita Chatterjee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1497-0388; OpenAlex author ID A5045279414. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2015: 2 papers

Papers 2

  1. Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer. Co-author DOI 10.1038/srep10867↗
  2. MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways. First author DOI 10.1080/15384101.2015.1104437↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Meredith Ann Morgan · 2 shared papers, 2015 · strength 0.09
  2. Terence Marques Williams · 2 shared papers, 2015 · strength 0.09
  3. Adriana Estrada‐Bernal · 1 shared paper, 2015 · strength 0.05
  4. Edgar Ben‐Josef · 1 shared paper, 2015 · strength 0.04
  5. Thomas Ludwig · 1 shared paper, 2015 · strength 0.04
  6. Mark M. Zalupski · 1 shared paper, 2015 · strength 0.04
  7. Tanios Bekaii‐Saab · 1 shared paper, 2015 · strength 0.04
  8. Ching‐Shih Chen · 1 shared paper, 2015 · strength 0.04
  9. Gazala Naaz Khan · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.